Abstract
The demonstration that histamine, a normal constituent of animal tissues could be released in its pharmacologically active form in animals submitted to peptone or anaphylactic shock, led to extensive studies of other conditions in which this release could occur. The first demonstration of a direct histamine releasing action of a drug possessing basic groups in its molecule, was given by Alam and et al. (1939), who showed that curarine could release considerable amounts of histamine from dog muscle in vivo. Subsequent work by different groups of investigators showed that a great number of basic organic compounds, some having quite simple chemical structures, could provoke the release of histamine from non-sensitized tissues (Schild and Gregory, 1947; MacIntosh and Paton, 1949; Rocha e Silva and Schild, 1949, etc.). An important early outcome of these studies was the differentiation of this action from drug allergy, a condition which is also characterized by the release of histamine following exposure to certain organic compounds; however, in contrast to the basic histamine releasers, these act only on sensitized tissues. As shown in Table 1, the list of basic histamine releasers includes now over one hundred compounds, some only active in the experimental animal but others possessing considerable activity in the human subject, where they can give rise to “histaminic” symptoms such as flushing, tachycardia, itching, edema, gastrointestinal distress and bronchospasm. Several drugs of clinical importance, including curarizing agents, opium alkaloids, atropine, quinine, antibiotics, chloroquine and trypanocidal amidines have been shown to be potentially able to elicit these reactions (Lewis, 1927; Kirk and Henry, 1944; West, 1938; Grob and et al. 1947; Salter and White, 1949). Effective preventive or curative measures for the control of these side effects are available, and have been reviewed along with the discussion of proper skin tests to foretell histamine release in the human subject (Collier, 1956; Collier and MacAuley, 1952; Paton, 1959).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alam, M., G. V. Anrep, G. S. Barsoum, M. Talaat, and E. Wieninder: Liberation of histamine from skeletal muscle by curare. J. Physiol. (Lond.) 95, 148 (1939).
Amann, R., and E. Werle: Über Komplexe von Heparin mit Histamin und anderen Di-und Polyaminen Klin. Wschr. 34, 207 (1956).
Archer, G. T.: Release of histamine from mast cells by tissue extracts. Nature (Lond.) 182, 727 (1958).
Arunlarshana, O.: Histamine release by antihistaminics. J. Physiol. (Lond.) 119, 47 P (1953).
Arvy, L.: Action de doses répétés d’un dérivé de la méthylamine sur la richesse du tissue conjonctif and des ganglions lymphatiques en labrocytes chez le rat. C. R. Soc. Biol. (Paris) 150, 2071 (1956).
Arvy, L., B. N. Halpern and T. Neveu: Modifications morphologiques de labrocytes and corrélations avec la mise en liberté de l’histamine endogène après injection d’une butylamine substitutive (1935L) donnée de propriétés histamino-libératrices chez le rat. C. R. Soc. Biol. (Paris) 150, 2074 (1956).
Baltzly, R., J. S. Buck, E. J. DE Beer, and F. A. Webb: A family of long-acting depressors. J. Amer. them. Soc. 71, 1301 (1949).
Barnes, J.: Toxic reactions to meprobamate. J. Irish med. Ass. 41, 119 (1957).
Beaujean, M., and J. Lecomte: Sur l’activité histamino-libératrice du polybrène. C. R. Soc. Biol. (Paris) 154, 437 (1960).
Beraldo, W. T.: Formation of bradykinin in anaphylactic and peptone shock. Amer. J. Physiol. 163, 283 (1950).
Bernstein, I. L., and S. M. Feinberg: Liberation of histamine from human skin. Effect of an anti-histamine and hydrocortisone on the activity of the histamine liberator, compound 48/80. J. Allergy 27, 231 (1956).
Bhattacharya, B. K., and G. P. Lewis: The release of 5-hydroxytryptamine by histamine liberators. Brit. J. Pharmacol. 11, 202 (1956a).
Bhattacharya, B. K., and G. P. Lewis: The effects of reserpine and compound 48/80 on the release of amines from the mast cells of rats. Brit. J. Pharmacol. 11, 411 (1956b).
Bignami, G.: Pharmacological studies about a new derivative possessing histamine-releasing action, the sebacic diamide of 4-phenyl-4-amino ethyl-N-methylpiperidine (1665). Farmaco 17, 24 (1962).
Binet, L., and D. QuivY: Libération d’héparine dans le chien traité par l’alkaloïde sinoménine. C. R. Acad. Sci. (Paris) 244, 1579 (1957).
Binet, L., and D. Quivy: Sur la libération d’histamine déterminée chez le rat par l’injection locale de 5-hydroxytryptamine dans diverses conditions expérimentales. C. R. Acad. Sci. (Paris) 247, 75 (1958).
Bodman, R. I.: Evaluation of two synthetic curarizing agents in conscious volunteers. Brit. J. Pharmacol. 7, 409 (1952).
Borin, A., and G. Jasmin: Dosage de l’histamine chez le rat traité au 48/80. Rev. canad. Biol. 18, 53 (1959).
Boreus, L. O.: A comparison of mast cell reactions in rat, hamster and guinea pig. Acta physiol, stand. 49, 251 (1960).
Boseila, A. W., and G. Asboe-Hansen: Influence of compound 48/80, protamine and other substances on rabbit basophils in vitro. Proc. Soc. exp. Biol. (N. Y.) 101, 198 (1959).
Boyd, J. F., and A. N. Smith: The effect of histamine and a histamine-releasing agent (compound 48/80) on wound healing. J. Path. Bact. 78, 379 (1959).
Boyd, J. F., and A. N. Smith: The effect of compound 48/80 on the autograft and homograft reaction. Brit. J. exp. Path. 41, 259 (1960).
Braunsteiner, H. Von, E. Mitsotakis and N. Thumb: Über die Wirkung von Diamino-decan auf Mastzellen und basophile Leucozyten. Blut 3, 255 (1957).
Brocklehurst, W. E., J. H. Humpiirey, and W. L. M. Perry: The role of histamine in cutaneus antigen-antibody reaction in the rat. J. Physiol. (Lond.) 129, 205 (1955).
Brodie, B. B., A. Pletscher, and P. A. Shore: Evidence that serotonin has a role in brain function. Science 122, 968 (1955).
Burkhalter, A., V. H. Cohn JR., and P. A. Shore: Effect of reserpine, serotonin and 5-hydroxyptamine on rabbit platelet histamine in vivo and in vitro. Biochem. Pharmacol. 3, 328 (1960).
Burstein, M., and J. L. Parrot: Elévation de l’histaminémie chez le chien k la suite de l’injection d’une forte dose d’atropine. C. R. Soc. Biol. (Paris) 143, 251 (1949).
Bushby, S. R. M., and A. F. Green: The release of histamine by polymyxin B and polymyxyn E. Brit. J. Pharmacol. 10, 215 (1955).
Butler, E. B.: Case of hypersensitivity to pethidine in woman in labour. Brit. med. J. 1951 II, 715.
Cahen, R., and S. Aubron: Effet histaminogène de la morpholinéthyl morphine. C. R. Acad. Sci. (Paris) 251, 3111 (1960).
Carmo, R. J., and W. Dias DA Silva: Effect of the intracerebral injection of compound 48/80 in the rat. Study of its mechanism of action. Ciência e Cultura 14, 241 (1962).
Carvalho, P., A. P. Corrado, A. M. Rothschild, and O. Vital Brazil: Unpublished results (1962).
Cass, R., and P. B. Marshall: Effect of adrenocortical hormones on tissue histamine and 5-hydroxytryptamine. Arch. int. Pharmacodyn. 136, 311 (1962).
Chakravarty, N.: The mechanism of histamine release in anaphylactic reaction in guinea pig and rat. Acta physiol. scand. 48, 146 (1960).
Chakravarty, N. R., B. HÖGberg, and B. UvnÄS: Mechanism of the release by compound 48/80 of histamine and of a lipid soluble smooth muscle stimulating principle (“Srs”). Acta physiol. scand. 45, 255 (1959).
Charlier, R., M J Dallemagne and E. Philippot: Propriétés hypotensives d’une butyl amine substituée. Arch. int. Pharmacodyn. 100, 127 (1954).
Cheymol, J., J. Thuillier, and P. MouillÉ: So-called histaminogenic effects of natural and synthetic curares. Ann. pharm. franç. 9, 705 (1951).
Code, C. F., D. T. Cody, M. Hurn, J. C. Kennedy, and M. J. Strickland: The simultaneous release of histamine and a histamine-destroying factor during anaphylaxis in rats. J. Physiol. (Lond.) 156, 207 (1961).
Collier, H. O. J.: Release of histamine-clinical considerations. Ciba Found. Symp. on Histamine, p. 155. London: Churchill 1956.
Collier, H. O. J. and B. Macauley: The pharmacological properties of “Laudolissin”, a long acting curarizing agent. Brit. J. Pharmacol. 7, 398 (1952).
CoisRoe, J. H., and R. D. Dripps: The histamine like actions of curare and tubocurarine injected intracutaneously and intraarterially in man. Anesthesiology 7, 260 (1946).
Coppola, J. A., and J. R. Dipalma: Histamine as a factor in tolerance to levarterenol. Amer. J. Physiol. 202, 114 (1962).
Czarnecki, E., J. Kiersz and E. Mietkiewski: Changements survenues dans le sang & la suite du choc consécutif aux injections de colorants. Int. Arch. Allergy, 285, 292 (1950).
Dale, H. H.: Antihistamine substances. Brit. med. J. 1948 II, 281.
Danon, A. P., and H. Moussatché: Influence of anabolic glycolysis on release of histamine in the guinea pig and rat anaphylactic reaction in vitro. Nature (Lond.) 192, 361 (1961).
Darlow, G.: Reaction between histamine liberators and phosphates. J. Physiol. (Lond.) 131, 13P (1955).
Dews, P. B., A. L. Wnuck, R. V. Fanelli, A. E. Light, J. A. Tallaben, S. Norton, C. H. Ellis, and E. J. DE Beer: The pharmacology of n° 48/80, a long-acting vaso depressor drug. J. Pharmacol. exp. Ther. 107, 1 (1953).
Diamant, B., and B. Uvnäs: Evidence for energy requiring processes in histamine release and mast cell degranulation in rat tissues induced by compound 48/80. Acta physiol. scand. 53, 315 (1961).
Dias DA Silva, W., A. D. L. Fernandes, and W. T. Beraldo: Release of histamine by dextran and its inhibition by carbohydrates and inhibitors of anaphylaxis. Ciência e Cultura 14, 239 (1962).
Eichler, O., and F. Barfuss: Histamingehalt im Blut bei Infusion von Adrenalin und Histamin. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 195, 245 (1940).
Eichler, O., and. G. Speda: Histamin im Plasma und Atmung. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 195, 153 (1940).
Eldridge, E., and W. D. M. Paton: The release of histamine from cat’s isolated perfused skin by amino-acids. J. Physiol. (Loud.) 124, 27P (1954).
Ellis, C. H., A. Van Harreveld, and F. J. Wolfgram: A study of the hemodynamic actions of histamine and 1,10-diaminodecane in cats. Arch. int. Pharmacodyn. 97, 287 (1954).
Evans, A. G. J., P. A. Nasmyth, and H. C. Stewart: The fall of blood pressure caused by intravenous morphine in rat and cat. Brit. J. Pharmacol. 7, 542 (1952).
Fawcett, D. W. Cytological and pharmacological observations on the release of histamine by mast cells. J. exp. Med. 100, 217 (1954).
Feinberg, S. M., A. R. Feinberg, J. Rebrun, and S. Malkiel: Liberation and depletion of histamine from human skin. Comparison of effects of specific antigens and a new histamine liberator, compound 48/80. Quart. Bull. Northw. Univ. med. Sch. 28, 246 (1954).
Feinberg, S. M., and L. A. Sternberger: Action of histamine liberator compound 48/80 in the guinea pig. J. Allergy 26, 170 (1955).
Feldberg, W., and P. Greengaard: Release of histamine from the perfused sciatic nerve by 48/80. J. Physiol. (Lond.) 133, 63 P (1956).
Feldberg, W., and B. Holmes: The effect of muscular contraction and of curarine on acid gastric secretion in cats. J. Physiol. (Lond.) 99, 3 P (1941).
Feldberg, W., and J. Lecomte: Release of histamine by a substituted butylamine (L. 1935): Comparison with compound 48/80. Brit. J. Pharmacol. 10, 254 (1955).
Feldberg, W., and A. A. Miles: Regional variations of increased permeability of skin capillaries by a histamine liberator and their relation to the histamine content of the skin. J. Physiol. (Lond.) 120, 205 (1953).
Feldberg, W., and J. L. Mongar: Comparison of histamine release by compound 48/80 and acetylcholine on perfused tissues. Brit. J. Pharmacol. 9, 197 (1954).
Feldberg, W., and W. D. M. Paton: Release of histamine from skin and muscle in the cat by opium alkaloids and other histamine liberators. J. Physiol. (Lond.) 114, 490 (1951).
Feldberg, W., and M. Schachter: Histamine release by horse serum from skin of the sensitized dog and the nonsensitized cat. J. Physiol. (Lond.) 118, 124 (1952).
Feldberg, W., and A. N. Smith: Release of histamine by tryptamine and 5-hydroxytryptamine. Brit. J. Pharmacol. 8, 406 (1953).
Feldberg, W., and A. N. Smith: The role of histamine release for the motor effects of histamine liberators on the guinea pig ileum preparation. J. Physiol. (Lend.) 124, 219 (1954).
Feldberg, W., and J. Talesnik: Reduction of tissue histamine by compound 48/80. J. Physiol. (Lond.) 120, 550 (1953).
Garan, R. S.: Histamin-Freisetzung in der Lunge durch Reizstoffbeatmung. NaunynSchmiedeberg’s Arch. exp. Path. Pharmak. 188, 250 (1938).
Garcia-Arocha, H., J. G. Ashwin, and A. L. Grossberg: Release of histamine by protamine and polylysine. Abstr. Comm. XI. Int. Physiol. Congr. Montreal, p. 378 (1953).
Gerendas, M., I. Csefko, and M. D. F. Udvardy: Histamine-Heparin-thrombin chain mechanism. Nature (Lond.) 162, 257 (1948).
Gershon, S., and F. H. Shaw: Morphine and histamine release. J. Pharm. Pharmacol. 10, 22 (1958).
Gertner, S. B.: The effect of compound 48/80 on ganglionic transmission. Brit. J. Pharmacol. 10, 103 (1955).
Goodman, L. S., and A. Gilman: The pharmacological basis of therapeutics. P. 616. New York: Macmillan 1955.
Goth, A., W. L. Nash, M. Nagler, and J. Holman: Inhibitors of histamine release in experimental diabetes. Amer. J. Physiol. 191, 25 (1957).
Graham, H. T., O. H. Lowry, N. Wahl, and M. K. Priebat: Mast cells as sources of tissue histamine. J. exp. Med. 102, 307 (1955).
Grob, D., J. L. Lilienthal JR., and A. M. Harvey: On certain vascular effects of curare in man. The “histamine” reactions. Johns Hopk. Hosp. Bull. 80, 299 (1947).
Grossberg, A. L., and H. Garcia-Arocha: Histamine liberation in vitro and mode of binding of histamine in tissues. Science 120, 762 (1954).
Hagen, P.: The intracellular distribution of histamine in dog’s liver. Brit. J. Pharmacol. 9, 100 (1954).
Hagen, P., R. J. Barrnett, and F. L. Lee: Biochemical and electron microscopic study of particles isolated from mastocytoma cells. J. Pharmacol. exp. Ther. 126, 91 (1959).
Halpern, B. N.: Histamine release by long chain molecules. Ciba Found. Symposium on Histamine, p. 92. London: Churchill 1956.
Halpern, B. N.: Substances histamino-libératrices and processus de libération de l’histamine endogène. Actualités pharmacol. 13, 109 (1960).
Halpern, B. N., M. Briot, P. Liacopoulos, T. Neveu and H. Branellec: Propriétés histamino-libératrices d’une butylamine substituée (1935L) chez le chien. C. R. Soc. Biol. (Paris) 150, 1302 (1956).
Halpern, B. N., M. Liacopoulos-Briot, T. Neveu and P. Liacopoulos: Propriétés histamino-libératrices d’une butylamine substituée, le 1935 L chez le rat. C. R. Soc. Biol. (Paris) 151, 853 (1957).
Halpern, B. N., P. Liacopoulos and M. Liacopoulos-Briot: Recherches sur les substances exogènes and endogènes agissant sur la perméabilité capillaire and leurs antagonistes. Arch. int. pharmacodyn. 119, 56 (1959a).
Halpern, B. N., T. Neveu and A. Branellec: Modalités de la libération d’histamine par diverses substances histamino-libératrices en hypothermie profonde. C. R. Soc. Biol. (Paris) 153, 14 (1959b).
Harris, A. F., A. Saifter, and S. R. Weintraub: Interaction of compound 48/80 and stilbamidine with Strandin. Proc. Soc. exp. Med. 107, 35 (1961).
Higginbotham, R. D.: Studies on the functional interrelationship of fibroblasts and ground substance imunopolysaccharides. Ann. N. Y. Acad. Sci. 73, 186 (1958).
Higginbotham, R. D. and T. F. Dougherty: Fate of shed mast cell granules. Proc. Soc. exp. Biol. 92, 256 (1956).
HÖGberg, B., G. Thufvesson, and B. UvnÄS: Histamine liberation produced in the perfused paw of the cat by 48/80 and extracts from jellyfish (Cynea capillata) and Eelworm (Ascaris Lumbricoides) from swine. Acta physiol. scand. 38, 135 (1956).
HÖGberg, B., and B. UvnÄS: Fragmentation of mast cells by some phenothiazine derivates. Acta them. stand. 11, 1092 (1957).
HÖGberg, B., and B. UvnÄS: Further observations on the disruption of rat mesentery mast cells caused by compound 48/80, antigen-antibody reaction, lecithinase A and decylamine. Acta physiol. scand. 48, 133 (1960).
Humphrey, J. H., and R. Jaques: The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions in vitro. J. Physiol. (Lond.) 128, 9 (1955).
Irino, S.: Effect of histamine releasers and of anti-inflammatory drugs on the egg-white edema of rat’s hind paws in relation to skin histamine. Acta Med. Okayama 12, 93 (1958).
Jaques, R., and K. KÖTtner: Selektive Farbstofferdrängung an biogenen Polyelektrolyten als Modell für die Liberation biogener Amine. Heiv. physiol. pharmacol. Acta 19, 335 (1961).
Tori, A., A. P. BentivoGlio, and S. Garattini: The mechanism of the local inflammatory reaction induced by compound 48/80 and dextran in rats. J. Pharm. Pharmacol. 13, 617 (1961).
Junqueira, L. C. U., and B. BEiGuelman: Studies on the in vitro action of compound 48/80, a formaldehyde condensation product on rat mast cells. Tex. Rep. Biol. Med. 13, 69 (1953).
Kimura, E. T., P. R. Young, and D. M. Ebert: Further studies on hexadimethrine bromide (polybrene) — an antiheparin agent. Toxicol. appl. Pharmacol. 1, 560 (1959).
Kirk, R., and A. J. Henry: Observations on the toxicity of stilbamidine. Ann. trop. Med. Parasit. 38, 99 (1944).
Klotz, S. D., and C. Bernstein: Allergy to meprobamate with some observations regarding the tranquilizing drugs. Sth. med. J. (Bgham, Ala.) 50, 1478 (1957).
Kocx, J., and J. Szerb: Liberation of histamine by adrenaline from isolated lung. Arch. int. Pharmacodyn. 81, 91 (1950).
KÖKsal, M.: Extraction of a heparin-like substance from mast cell granules in mouse connective tissues. Nature (Loud.) 172, 733 (1953).
Kowalewski, K.: Effect of a histamine liberator and of serotonin on plasma pepsinogen in rats. Arch. in Pharmacodyn. 129, 71 (1960).
Kittner, K., H. Majer, G. Huber and R. Jaques: Untersuchungen an Ionenaustauschmodellen zum Verständnis der Physiologie biogener Amine. Austauschversuche an einem Schwefelsäuregruppen tragenden Harz zum Verständnis von sogenannten HistaminLiberationsvorgängen. Experientia (Basel) 17, 371 (1961).
Lagunoff, D., and E. P. Benditt: Mast cell degranulation and histamine release observed in a new in vitro system. J. exp. Med. 112, 571 (1960).
Lahirr, S. C., and W. E. Brocklehurst: Bradykinin and anaphylactic shock. Brit. J. Pharmacol. 17, 5 (1961).
Landmesser, C. M.: Study of bronchoconstrictor and hypotensive actions of curarizing drugs. Anesthesiology 8, 506 (1947).
LE Blanc, J.: Effect of chlorpromazine on number of mast cells and of certain formed elements of blood. Proc. Soc. exp. Biol. (N. Y.) 97, 238 (1958).
Lecomte, J.: Libération d’histamine par certains dérivés d’acridine. C. R. Soc. Biol. (Paris) 149, 1060 (1955a).
Lecomte, J.: Pouvoir histamino-libérateur de la chlorpromazine. C. R. Soc. Biol. (Paris) 149, 1693 (1955b).
Lecomte, J.: Libération de l’histamine endogène chez l’homme. Arch. int. Pharmacodyn. 101, 375 (1955c).
Lecomte, J.: Propriétés anti-histaminiques des dérivés décarboxylés de la cystéine (cystéamine and cystamine). Arch. int. Physiol. 63, 291 (1955d).
Lecomte, J.: Endogenous histamine liberation in man. Ciba Foundation Symposium on Histamine, p. 173. London: Churchill 1956a.
Lecomte, J.: Déplétion en histamine and phénomène d’Arthus chez de lapin. Int. Arch. Allergy 8, 343 (1956 b).
Lecomte, J.: Liberation of endogenous histamine in man. J. Allergy 28, 102 (1957).
Lecomte, J. and M. L. Beaumariage: Réactions anaphylactiques cutanées locales du Coq. C. R. Soc. Biol. (Paris) 151, 1452 (1957).
Lecomte, J. and L. Borensztajn: Libération d’histamine and intradermoréaction tuberculinique chez l’homme. Acta allerg. (Kbh.) 6, 89 (1953).
Lecomte, J. and P. Fischer: Sur la libération de l’histamine tissulaire provoquée par l’adrénochrome and ses dérivés. Arch. in Physiol. Biochim. 65, 396 (1957).
Lecomte, J. and J. M. Petit: Effets de l’histamine and des processus d’histamino-libération sur la fonction pulmonaire. Int. Arch. Allergy 17, 10 (1960).
Leitch, J. L., and T. J. Haley: Effect of 48/80 and X-irradiation on urinary histamine in the rat. Fed. Proc. 14, 363 (1955).
Lewis, T.: The blood vessels of the human skin and their responses. London: Shaw & Son, 1927.
Macaluso, M. P., A. Salerno, and A. Friscia: Researches on the so-called degranulation of mast cells produced by histamine liberators. Boll. Soc. ital. Biol. sper. 37, 21 (1961).
Macintosh, F. C.: Histamine and intracellular particles. Ciba Found. Symposium on Histamine p. 20. London: Churchill 1956.
Macintosh, F. C. and W. D. H. Paton: The liberation of histamine by certain organic bases. J. Physiol. (Lond.) 109, 190 (1949).
Mahfouz, M.: Fate of tubo-curarine in the body. Brit. J. Pharmacol. 4, 295 (1949).
Mayeda, H.: Release of histamine by sinomenine. Jap. J. med. Sci. IV. Pharmacol. 3, 62 (1953).
Mccubbin, J. W., and I. H. Page: Nature of the hypotensive action of a thiophanium derivative (Ro 2–2222) in dogs. J. Pharmacol. exp. Ther. 105, 437 (1952).
Mcilreath, F. J. JR.: Some evidence concerning the mode of binding of histamine. Canad. J. Biochem. 37, 151 (1959).
Mcintire, F. C.: Personal communication 1962.
Mcintire, F. C., L. W. Roth, and M. Sproull: Histamine release in rabbit blood by simple molecules, inhibition and reaction rate studies. Amer. J. Physiol. 167, 233 (1951).
MÉLon, J., and J. Lecomte: Influence de la libération pharmacodynamique de l’histamine cutanée sur les réactions anaphylactiques locales de type immédiat. Acta allerg. (Kbh.) 12, 245 (1958).
Miles, A. A., and E. M. Miles: Vascular reactions to histamine, histamine liberators and leukotaxine in the skin of guinea pigs. J. Physiol. (Lond.) 118, 228 (1952).
Mitchell, R., P. J. Newman, D. Macgillivray, and B. B. Clark: Evaluation of histamine liberator activity illustrated by a thiophanium compound, Ro 2–2222. Fed. Proc. 10, 325 (1951).
Mongar, J. L.: Measurement of histamine-releasing activity. Ciba Found. Symposium on Histamine, p. 74. London: Churchill 1956.
Mongar, J. L.: Effect of chain length of aliphatic amines on histamine potentiation and release. Brit. J. Pharmacol. 12, 140 (1957).
Mongar, J. L., and H. O. Schild: A comparison of the effects of anaphylactic shock and of chemical histamine releasers. J. Physiol. (Lond.) 118, 461 (1952).
Mongar, J. L., and H. O. Schild: Quantitative measurement of the histamine releasing activity of a series of monoalkyl amines using minced guinea pig lung. Brit. J. Pharmacol. 8, 103 (1953).
Mongar, J. L., and H. O. Schild: Effect of antigen and organic bases on intra-cellular histamine in guinea pig lung. J. Physiol. (Lond.) 131, 207 (1956).
Mongar, J. L., and H. O. Schild: Inhibition of the anaphylactic reaction. J. Physiol. (Lond.) 135, 301 (1957a).
Mongar, J. L., and H. O. Schild: Effect of temperature on the anaphylactic reaction. J. Physiol. (Loud.) 135, 320 (1957b).
Mongar, J. L., and H. O. Schild: The effect of calcium and pH on the anaphylactic reaction. J. Physiol. (Lond.) 140, 272 (1958).
Mongar, J. L., and R. F. Whelan: Histamine release by adrenaline and D-tubocurarine in the human. J. Physiol. (Lund.) 120, 146 (1953).
Moran, N. C., G. P. Quinn, and W. M. Butler JR.: An analysis of the histamine-like actions of oxypanamine. J. Pharmacol. exp. Ther. 125, 85 (1959).
Mota, I.: Effect of antigen and octylamine on mast cells and histamine content of sensitized guinea pig tissues. J. Physiol. (Lond.) 147, 425 (1959).
Mota, I., W. T. Beraldo, and L. C. U. Junqueira: Protamine-like property of compound 48/80 and stilbamidine and their action on mast cells. Proc. Soc. exp. Biol. (N. Y.) 83, 455 (1953).
Mota, I., W. T. Beraldo, A. G. Ferri, and L. C. U. Junqueira: Intracellular distribution of histamine. Nature (Lund.) 174, 698 (1954).
Mota, I., W. T. Beraldo, A. G. Ferri, and L. C. U. Junqueira: Action of 48/80 on the mast cell population and histamine content of the wall of the gastrointestinal tract of the rat. Ciba Found. Symposium on Histamine, p. 47. London: Churchill 1956b ).
Mota, I., and W. Dias DA Silva: The anti-anaphylactic and histamine releasing properties of the anti-histamines. Their effects on the mast cells. Brit. J. Pharmacol. 15, 396 (1960).
Mota, I., A. G. Ferri, and S. Yoneda: The distribution of mast cells in the digestive tract of laboratory animals; its bearing on the problem of the localization of histamine in tissues. Quart. J. micr. Sci. 97, 251 (1956a).
Mota, I., and T. Ishii: Inhibition of mast cell disruption and histamine release in rat anaphylaxis in vitro. Comparison with compound 48/80. Brit. J. Pharmacol. 15, 82 (1960).
Mota, I., and I. Vugman: Action of compound 48/80 on the mast cells and histamine content of guinea pig tissues. Brit. J. Pharmacol. 11, 304 (1956).
Moulton, R., W. G. Spector, and D. A. Willoughby: Histamine release and pain production by xanthosine and related compounds. Brit. J. Pharmacol. 12, 365 (1957).
MoussatchÉ, H., and A. P. Danon: Influence of oxidative phosphorylation inhibitors on the histamine release in the anaphylactic reaction in vitro. Experientia (Basel) 14, 414 (1958).
Nasmyth, P. A., and H. C. Stewart: The release of histamine by opium alkaloids. J. Physiol. (Lund.) 111, 19P (1950).
Nishiyama, R., K. Tasaka, and S. Irino: The sites of action of some histamine releasing substances in the dog. Acta Med. Okayama 11, 133 (1957).
Nitescu, I. I., M. Grinspan, and M. Cirstea: Interaction of curare and anaphylactic shock in the dog. Stu. Genet. Fisiol. (Bucarest) 4, 127 (1959).
Norton, S.: Quantitative determination of mast cell fragmentation by compound 48/80. Brit. J. Pharmacol. 9, 494 (1954).
Norton, S. and E. J. Debeer: Effect of some antibiotics on rat mast cells in vitro. Arch. int. Pharmacodyn. 102, 352 (1955).
Osler, A. G., H. G. Randall, B. M. Hill, and Z. Ovary: The participation of complement in the formation of anaphylatoxin. J. exp. Med. 110, 311 (1959).
Papacostas, C. A., and E. R. Loew: Cardiovascular and respiratory effects of lethal doses of histamine and compound 48/80 in rabbits. Proc. Soc. exp. Biol. (N. Y.) 100, 604 (1959).
Papacostas, C. A., E. R. Loew and G. B. West: Studies on the toxicology of a histamine liberator, compound 48/80. Arch. int. Pharmacodyn. 120, 353 (1959).
Parratt, J. R., and G. B. West: Histamine liberation in the hamster. Arch. int. Pharmacodyn. 113, 209 (1957a).
Parratt, J. R., and G. B. West: Release of 5-hydroxytryptamine and histamine from tissues of the rat. J. Physiol. (Lond.) 137, 179 (1957b).
Parrot, J. L., and C. Laborde: Captation de l’histamine par l’héparine. C. R. Soc. Biol. (Paris) 145, 1047 (1951).
Paton,W. D. M.: Compound48/80, apotent histamine liberator. Brit. J. Pharmacol. 6, 499 (1951).
Paton,W. D. M.: The mechanism of histamine release. Ciba Found. Symposium on Histamine, p. 59. London: Churchill 1956.
Paton,W. D. M.: Histamine release by compounds of simple chemical structure. Pharmacol. Rev. 9, 269 (1957).
Paton,W. D. M.: The effects of muscle relaxants other than muscular relaxation. Anesthesiology 20, 453 (1959).
Paton,W. D. M., and M. Schachter: The influence of an anti-histamine drug on the release of histamine in the unanesthetized dog. Brit. J. Pharmacol. 6, 509 (1951).
Payne, J. P.: Histamine release during controlled hypotension with arfonad. Proc. World Congr. Anesthesiology, p. 180 (1955).
Pellerat,.J., and M. Murat: Action des anti-histaminiques de synthèse sur l’histaminémie. C. R. Soc. Biol. (Paris) 140, 297 (1946).
Quastel, J. H., and A. H. Wheatley: The effects of amines on oxidations of the brain. Biochem. J. 27, 1609 (1933).
Randall, L. O., W. G. Peterson, and G. Lehmann: The ganglionic blocking action of thiophanium derivatives. J. Pharmacol. exp. Ther. 97, 48 (1949).
Reid, G.: Liberation of histamine and heparin by tubocurarine and its circulatory effects in the dog. Aust. J. exp. Biol. med. Sci. 28, 465 (1950).
Reuse, J. J.: Modifications circulatoires au cours du choc anaphylactique and après administration d’un libérateur d’histamine (composé 48/80). Arch. int. Pharmacodyn. 93, 122 (1953).
Riley, J. F.: The effects of histamine-liberators on the mast cells of the rat. J. Path. Bact. 65, 471 (1953).
Riley, J. F.: The mast cells. Edinburgh and London: Livingstone 1959.
Riley, J. F., and G. B. West: Tissue mast cells. Studies with a histamine liberator of low toxicity (compound 48/80). J. Path. Bact. 69, 269 (1955a).
Riley, J. F., and G. B. West: Histamine liberation in the rat and mouse. Arch. int. Pharmacodyn. 102, 304 (1955b).
Rochaesilva, M.: Concerning the mechanism of anaphylactic and tryptic shock. J. Immunol. 40, 399 (1941).
Rochaesilva, M.: Unexpected reactions in pharmacology. Thesis, São Paulo (1952).
Rochaesilva, M.: Central effects produced by injection of 48/80 into the cerebral ventricles of mice. Brit. J. Pharmacol. 14, 243 (1959).
Rochaesilva, M. and A. M. Rothschild: Anaphylatoxin, histamine depletion and skin reactions in the rat. Nature (Loud.) 175, 987 (1955).
Rochaesilva, M. and A. M. Rothschild: Experimental design for bioassay of a material inducing strong tachyphylactic effect (anaphylatoxin). Brit. J. Pharmacol. 11, 252 (1956).
Rochaesilva, M. and H. O. Schild: Release of histamine by D-tubocurarine from the isolated diaphragm of the rat. J. Physiol. (Lond.) 109, 448 (1949).
Rothschild, A M: Effect of metabolic inhibitors on the release of histamine by anaphylatoxin and by antigen in vitro. Experientia (Basel) 17, 555 (1961).
Rothschild, A M: Unpublished results (1962).
Rothschild, A M: Effect of catecholamines and their chloroanalogues on the in vitro release of histamine from rat peritoneal fluid cells. Biochem. Pharmacol. 11, 979 (1962a).
Rothschild, A M, and E. Garcia Lima: Effect of dinitrophenol and glucose on the release of histamine and of serotonin from rabbit platelets by anaphylatoxin in vitro: To be published (1962).
Rothschild, A M., I. Vugnian, and M. Rocha E Silva: Metabolic studies on the release of histamine by compound 48/80 in the rat diaphragm. Biochem. Pharmacol. 7, 248 (1961).
Salter, W. T., and M. L. White: Morphine sensitivity. Anesthesiology 10, 553 (1949).
Schachter, M.: The release of histamine by pethidine, atropine, quinine and other drugs. Brit. J. Pharmacol. 7, 646 (1952).
Schachter, M.: Anaphylaxis and histamine release in the rabbit. Brit. J. Pharmacol. 8, 412 (1953).
Schayer, R. W., and R. L. Smiley: Binding and release of radioactive histamine in intact rats. Amer. J. Physiol. 177, 401 (1954).
Schayer, R. W., K. J. Davis, and R. L. Smiley: Evaluation of histamine release in rats by analysis of urine. Amer. J. Physiol. 181, 484 (1955).
Schayer, R. W., K. Y. Wu, and R. L. Smiley: Sources of urinary histamine in the rat. Amer. J. Physiol. 179, 481 (1954).
Schild, H. O.: Release of histamine by ammonia. Nature (Lond.) 164, 24 (1949).
Schild, H. O., and R. A. Gregory: Liberation of histamine from striated muscle by curarine, strychnine and related substances. Abstr. Comm. Xvii. Intern. Congr. Physiol. Oxford, p. 208 (1947).
Selye, H.: Effect of Acth and cortisone upon an anaphylactoid reaction. Canad. med. Ass. J. 61, 553 (1949).
Shelesnyak, M. C., and P. F. Kraicer: La pyrathiazine est un anti-histaminique capable de provoquer le déciduone utérin par libération d’histamine dans l’organisme. C. R. Acad. Sci. (Paris) 248, 2126 (1959).
Sicuteri, F., and R. Monfardini: Protected histamine release in man, first therapeutical experiments with 48/80. Comm. Iii. Intern. Congr. Allergol. Paris (1958).
Sicuteri, F., M. Ricci and G. Franchi: Asthme provoquée dans le cobaye par des aérosols de l’histaminolibérateur, 48/80. Particularités symptomatologiques and histologiques. Comm. Iii. Intern. Congr. Allergol. Paris (1958).
Sicuteri, F.: Biologia e chimica della liberazione di istamina. Edizioni La Settimana Medica,Firenze(1961).
Sicuteri, F., and E. Romagnoli: Behaviour of pressure and pulse of cerebral fluid in man during release of histamine by compound 48/80. Acta allerg. (Kbh.) 15, 222 (1960).
Sicuteri, F., L. Salvini, G. Franchi, and S. Viola: Variations in the heparinemia and histaminemia during the action of the histamine releaser 48/80 in man. G. Clin. med. 60, 1378 (1959).
Smith, A. N.: The effect of compound 48/80 on gastric secretion in the cat. J. Physiol. (Lond.) 119, 233 (1953 a).
Smith, A. N.: Release of histamine by the histamine liberator compound 48/80 in cats. J. Physiol. (Lond.) 121, 517 (1953b).
Smith, A. N.: The experimental production of gastric ulcers by histamine releasing substances. Brit. J. Surg. 46, 157 (1958).
Smith, D. E.: Nature of the secretory activity of the mast cell. Amer. J. Physiol. 193, 573 (1958 a).
Smith, D. E.: Dynamics of release of histamine from tissue mast cells. Science 128, 207 (1958b).
Smith, D. E.: Influence of anti-histamine on mast cells disruption following X-irradiation. Proc. Soc. exp. Biol. (N. Y.) 97, 872 (1958e).
Smith, D. E., and Y. S. Lewis: Electron microscopy of the tissue mast cells. J. biophys. biochem. Cytol. 3, 9 (1957).
Smith, J. A., A. H. Lind, and R. I. Ryzoff: Production of bronchoconstriction by thiamine in guinea-pigs. Fed. Proc. 14, 141 (1955).
Sniper, W.: The estimation and comparison of histamine release by muscle relaxants in man. Brit. J. Anaesth. 24, 232 (1952).
Sollmann, T.: A Manual of Pharmacology. London and Philadelphia: Saunders 1948.
Sollmann, T., and J. D. Pilcher: Endermic reactions. J. Pharmacol. exp. Therap. 9, 309 (1917).
SÖMJÉN, G., and I. E. Uyldert: The effect of compound 48/80 on mammalian skeletal muscle. Brit. J. Pharmacol. 10, 413 (1955).
Staub, H.: Die Adrenalin-Histaminregulation, gleichzeitig Beitrag zum Antistinmechanismus. Rely. physiol. pharmacol. Acta 4, 539 (1946).
Staub, H., H. Bauer: Sympatolhistaminämie bei Psychopathie und vegetativer Störung. Schweiz. med. Wschr. 78, 1249 (1948).
Surres, A.: Bluthistaminbestimmungen nach intravenöser Adrenalininjektion bei allergischen und neurovegetativen Störungen. Schweiz. med. Wschr. 78, 662 (1948).
Szilagyi, T., A. Kover, and B. Csaba: Effect of hypothermia on histamine release induced by epinephrine infusion. Amer. J. Physiol. 199, 272 (1960).
Tasaka, K.: Histamine release and its inhibition by anti-histamines. Folia pharmacol. jap. 53, 1029 (1957).
Troquet, J., and J. Lecomte: On the histamine nature of complications caused by disulfiran. Rev. belge Path. 27, 180 (1960).
Ungar, G., and E. Damgaard: Tissue reaction to anaphylactic and anaphylactoid stimuli; proteolysis and release of histamine and heparin. J. exp. Med. 101, 1 (1955).
Ungar, G., T. Yamura, J. B. Isola, and S. Kobrin: Further studies on the role of proteases in the allergic reaction. J. exp. Med. 113, 359 (1961).
UvnÄS, B.: Mechanism of histamine release from mast cells. Chemotherapia (Basel) 3, 137 (1961).
UvnÄS, B., and I. L. Thon: Isolation of “biologically intact” mast cells. Exp. Cell Res. 18, 512 (1959).
UvnÄS, B., and I. L. Thon: Evidence for enzymatic histamine release from isolated rat mast cells. Exp. Cell. Res. 23, 45 (1961).
Van Arsdel, P., and R. E. Bray: On the release of histamine from rat peritoneal mast cells by compound 48/80. Effect of metabolic inhibitors. J. Pharmacol. exp. Ther. 133, 319 (1961).
Vane, J. R.: Some pharmacological actions of paludrine. Brit. J. Pharmacol. 4, 14 (1949).
Viana, H. M., and D.Brandão: Effects of phenothiazines and nonphenothiazine antihistaminics on tissue slices. Ciência e Cultura 14, 235 (1962).
Virno, M., S. B. Gertner, and D. Bovet: Action of histamine on the jugular pressure and cerebral circulation of the dog; effects of anti-histaminic drugs and a histamine liberatory agent. J. Pharmacol. exp. Therap. 118, 63 (1956).
Vogt, W.: The chemical nature of Darmstoff. J. Physiol. (Lond.) 137, 154 (1957).
Vugnian, I.: Factors which influence the release of histamine from the isolated diaphragm of the rat by compound 48/80. Thesis, Faculdade de Medicina de Ribeirâo Prêto, Brazil (1961).
Vugnian, I.: Influence of insulin and of glucose on the liberation of histamine from the isolated diaphragm of the rat by compound 48/80. Ciência e Cultura 14, 239 (1962).
Vugnian, I. and A. M. Rothschild: Effect of glucose and insulin on the histamine release by compound 48/80 from alloxan diabetic rats. Acta physiol. lat.-amer. 11, 108 (1961).
Waalkes, T. P., H. Coburn, and L. L. Terry: The effect of reserpine on histamine and serotonin. J. Allergy 30, 408 (1959).
Waser, P. G., and J. Itzbicki: Effects of psychotropic drugs on blood histamine in rat. Experientia (Basel) 15, 197 (1959).
Went, I., and E. Varga: Experimentelle Untersuchungen über die chemische Gegenregulation des Blutdruckes. Acad. Sci. Hung. 3, 377 (1952).
West, G. B.: Histamine in mast cell granules. J. Pharm. Pharmacol. 7, 80 (1955).
West, G. B.: Comparison of the release of histamine and 5-hydroxytryptamine from tissues of the rat, mouse and hamster. Int. Arch. Allergy 13, 336 (1958).
West, G. B.: Chemical nature and possible role of mediators in allergic reactions. Int. Arch. Allergy 18, 56 (1961).
West, R.: The pharmacology and therapeutics of curare and its constituents. Proc. roy. Soc. Med. 28, 565 (1935).
West, R.: The actions of curarine on the respiratory mechanism. J. Physiol. (Lond.) 91, 437 (1938).
West, R.: Bronchospasm and antihistamine drugs. Proc. roy. Soc. Med. 42, 625 (1949).
Westerholm, B.: In vitro release of histamine from cat skin by compound 48/80. Acta physiol. scand. 50, 41 (1960a).
Westerholm, B.: The influence of anoxia on 48/80 induced histamine release from cat skin. Acta physiol. scand. 50, 300 (1960b).
Wilson, C. W. M.: Factors influencing the urinary excretion of histamine in the rat. J. Physiol. (Lond.) 126, 141 (1954).
Zeppa, R., D. Grosskreuz, and K. Sugioka: Histamine release into the circulation by meperidine (Demerol). Proc. Soc. exp. Biol. (N. Y.) 106, 794 (1961).
Editor information
Rights and permissions
Copyright information
© 1966 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rothschild, A.M. (1966). Histamine Release by Basic Compounds. In: Rocha e Silva, M. (eds) Histamine and Anti-Histaminics. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 18 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12016-3_18
Download citation
DOI: https://doi.org/10.1007/978-3-662-12016-3_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-12018-7
Online ISBN: 978-3-662-12016-3
eBook Packages: Springer Book Archive